Our competing continuation application on the biochemistry of the exocrine pancreas is concerned with: 1/ NEW MAMMALIAN GUT-BRAIN PEPTIDES OF THE VIP/PHI/SECRETIN FAMILY STIMULATING THE EXOCRINE PANCREAS: we will isolate a) PHI variants and b) mammalian helodermin(s). Mammalian helodermins are parent peptide(s) of lizard helodermin, a pentatriacontapeptide-amide we isolated 2 years ago from the sublingual venom of the Helodermae lizard Gila Monster. We will purify these peptides from: a) """"""""post-secretinic"""""""" fractions from pig small intestine provided by Dr. Mutt); b) selected human endocrine tumors; and c) brain, gut, and stomach from rat. Once the amino acid sequence established and synthetic equivalents made available, their biochemical properties on the rat pancreas will be defined in terms of cyclic AMP levels, amylase secretion, binding to receptors, etc; 2/ SECRETIN, VIP and CCK RECEPTORS. To pursue the molecular characterization of secretin-preferring and VIP-preferring receptors, pancreatic membranes from rat (and accessorily from guinea pig and man) will be solubilized after crosslinking with new radioiodinated ligands. We hope to further purify CCK receptors by immunoaffinitychromatography with anti CCK receptor monoclonal antibodies or antibodies from the serum of patients with pernicious anaemia. Utilizing pancreatic receptors as a tool, VIP and secretin analogs specifically endowed with superagonist or antagonist properties and highly specific for each class of receptor will be taylored; 3/ MUSCARINIC RECEPTORS: the study of their effector coupling through regulatory protein(s) will help to delineate properties typical of the B subclass of M2 receptors (with intermediate affinity for pirenzepine); 4/ GUANINE NUCLEOTIDE REGULATORY PROTEINS Ns, Ni and Nx. We will try to identify Nx, a protein distinct from Ni and Ns that might allow the coupling of high affinity pancreatic CCK receptors and muscarinic receptors with phospholipase C; 5/ THE INTERMEDIARY METABOLISM OF THE EXOCRINE PANCREAS. We will focus our attention on 3 topics: 1) endogenous phospholipase A2 (distinct from secretory prophospholipase A2) and its possible role in stimulus-secretion coupling and as an agent of cell damage, using as standard of comparison a new type of phospholipase A2 we recently isolated from the venom of Heloderma suspectum; 2) the structure of a small regulatory phosphoprotein from pancreatic endoplasmic reticulum (Mr 21 kDa); and 3) the effect of """"""""invasive adenylate cyclase"""""""", an enzyme we wish to isolate from Bordetella pertussis. This bacterial enzyme, once in acinar cells, could be remarquably regulated by intracellular calmodulin and calcium fluxes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK017010-11
Application #
3225684
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1978-06-01
Project End
1990-08-31
Budget Start
1987-09-30
Budget End
1988-08-31
Support Year
11
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Free University of Brussels
Department
Type
DUNS #
City
Brussels
State
Country
Belgium
Zip Code
Gourlet, P; Woussen-Colle, M C; Robberecht, P et al. (1991) Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes. Eur J Biochem 195:535-41
Bounjoua, Y; Vandermeers, A; Robberecht, P et al. (1991) Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucinamide and secretin from the ovine small intestine. Regul Pept 32:169-79
Robberecht, P; Gourlet, P; Cauvin, A et al. (1991) PACAP and VIP receptors in rat liver membranes. Am J Physiol 260:G97-102
Lambert, M; Diem Bui, N; Christophe, J (1991) Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR 4-2J. Regul Pept 32:151-67
Gourlet, P; Svoboda, M; Cauvin, A et al. (1990) The sensitivity of dot immunoassay for the peptides helodermin, histidine-isoleucinamide (PHI) and histidine-methioninamide (PHM) increases after peptide cross-linking to proteins prefixed on nitrocellulose. J Immunol Methods 133:151-7
Waelbroeck, M; Tastenoy, M; Camus, J et al. (1990) Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol 38:267-73
Gossen, D; Tastenoy, M; Robberecht, P et al. (1990) Secretin receptors in the neuroglioma hybrid cell line NG108-15. Characterization and regulation of their expression. Eur J Biochem 193:149-54
Cauvin, A; Vandermeers-Piret, M C; Vandermeers, A et al. (1990) Rat PHI, PHI-GLY and PHV (1-42) stimulate adenylate cyclase in six rat tissue and cell membranes. Peptides 11:1009-14
Cauvin, A; Vandermeers, A; Vandermeers-Piret, M C et al. (1989) Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: identification of the large molecular form as peptide histidine valine-(1-42). Endocrinology 125:2645-55
Cauvin, A; Vandermeers, A; Vandermeers-Piret, M C et al. (1989) Peptide histidine isoleucinamide (PHI)-(1-27)-Gly as a new major form of PHI in the rat small intestine. Endocrinology 125:1296-302

Showing the most recent 10 out of 13 publications